Clinical Trials Browser

Phase 1 × Sodium Pertechnetate Tc 99m × 90 days × Clear all

NCT03120624 2026-02-04

VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer

Phase 1 Active not recruiting

34 enrolled 16 charts

Endometrial Neoplasms